share_log

RBC Capital Reiterates Sector Perform on Inovio Pharmaceuticals, Maintains $2 Price Target

Benzinga ·  May 11, 2023 10:06

RBC Capital analyst Gregory Renza reiterates Inovio Pharmaceuticals (NASDAQ:INO) with a Sector Perform and maintains $2 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment